Adventitial progenitor cells, including SCA-1 + and mesenchymal stem cells, are believed to be important in vascular remodeling. It has been shown that SCA-1 + progenitor cells are involved in neointimal hyperplasia of vein grafts, but little is known concerning their involvement in hyperlipidemia-induced atherosclerosis. We employed single-cell sequencing technology on primary adventitial mouse SCA-1 + cells from wild-type and atherosclerotic-prone (ApoE-deficient) mice and found that a group of genes controlling cell migration and matrix protein degradation was highly altered. Adventitial progenitors from ApoE-deficient mice displayed an augmented migratory potential both in vitro and in vivo. This increased migratory ability was mimicked by lipid loading to SCA-1 + cells. Furthermore, we show that lipid loading increased miRNA-29b expression and induced sirtuin-1 and matrix metalloproteinase-9 levels to promote cell migration. These results provide direct evidence that blood cholesterol levels influence vascular progenitor cell function, which could be a potential target cell for treatment of vascular disease.
INTRODUCTION
Atherosclerosis is a condition whereby the arteries supplying target organs, such as the brain and the heart, become occluded. It is a disease of chronic inflammation and the leading cause of heart ischemia (Lusis, 2000) . It is characterized by subendothelial retention of modified lipoproteins, causing local inflammation and neointimal lesion formation (Williams and Tabas, 1995) . This local effect exacerbates the activation and consequent loss of the endothelial cell (EC) layer and profound vascular smooth muscle cell (vSMC) proliferation, as well as recruitment of monocytes and activation of resident macrophages. Consequently, all three layers that comprise the vascular cell wall (adventitia, media, and EC) undergo remodeling with an accumulation of cellular and extracellular matrix (ECM) material. Over the last decade, vascular progenitors have been identified in the vessel wall in humans and rodents (Alessandri et al., 2001; Ferreira et al., 2007; Hill et al., 2010; Hu et al., 2004; Invernici et al., 2008; Passman et al., 2008; Psaltis et al., 2014; Sirker et al., 2009; Tang et al., 2012; Tavian et al., 2005; Tilki et al., 2009; Wu et al., 2008; Xu et al., 2003; Zengin et al., 2006) . The murine adventitia contains a heterogeneous population of progenitor/precursor cells with the majority of them expressing stem cell antigen 1 (SCA-1). In atherosclerotic arteries, the adventitial layer displays increased cell proliferation and inflammation (for review see Seidelmann et al., 2014) . Recent studies have highlighted the potential role of the adventitia in the development of neointimal lesion of vessel grafts Wong et al., 2013) . However, less is known about the involvement of vascular stem/progenitor cells in native atherosclerosis, the leading cause of cardiovascular death in the general population.
Resident vascular progenitors possess a bilineage potential, able to differentiate into vSMCs and ECs, both in vitro and in vivo (Hu et al., 2004; Torsney et al., 2005; Wong et al., 2013) . Utilization of an SM22-LacZ mouse model showed that SCA-1 + b-gal + cells could be traced to neointimal lesions, confirming their differentiation toward an SMC-like phenotype. When adventitial SCA-1 + (AdvSCA-1 + ) cells were applied to the external side of vein grafts, prior to isografting to ApoE knockout (KO) and wild-type (WT) mice, they were shown to contribute to lesions via unknown mechanisms. These murine SCA-1 + cells have been identified as the largest vascular progenitor cell population to date, with subpopulations expressing C-KIT and CD34 (Hu et al., 2004) . Bone marrow-derived circulating cells may serve as a second potential source of vascular progenitors. In support of this, SCA-1 + cells also express the macrophage/ monocyte marker CD45 (Psaltis et al., 2014) . Noseda et al. (2015) reported that there are at least two distinct types of SCA-1 + cells in the adult mouse heart, with one segregating to a cardiogenic potential and the other toward a vascular one. Previously, we demonstrated that SCA-1 + -derived vSMCs present in neointimal lesions originated from non-bone marrow-derived resident vascular progenitors (Hu et al., 2002a (Hu et al., , 2002b Xu et al., 2003) . Although adventitial progenitors have been proposed to contribute to vascular disease (Campagnolo et al., 2015; Chen et al., 2013; Hu et al., 2004; Passman et al., 2008; Psaltis et al., 2014; Tigges et al., 2013) 
RESULTS
A Gene Signature of a Heightened Migratory Capability in ApoE KO AdvSCA-1 + Cells WT mice do not develop atherosclerosis ( Figure S1A ). The ApoE KO mice develop neointimal lesions and endothelial layer lipid residues, along with an expanded adventitial layer from 6 months onward ( Figure S1B ). The adventitia and intima layers have been shown to contain SCA-1 + cells (Hu et al., 2004) . Immunolabeling of the descending aortas and the root of WT ( Figure 1A ) and ApoE KO aortas revealed an increase of SCA-1 + signal in both the adventitial and intimal layers of the mutant vascular wall ( Figure 1B ), as well as in vitro ( Figure S2C ). We confirmed this increase by en face immunolabeling of both descending and ascending aortas ( Figures 1C-1E ). To address the innate heterogeneity of the AdvSCA-1 + cell population, we collected unpassaged adventitial cells from both WT and ApoE KO mice, obviating potential bias from in vitro expansion. These cells were then enriched for SCA-1 surface expression prior to single-cell expression analysis. A total of 25,596 genes were analyzed between the two SCA-1 + cell populations ( Figure 2A ) and statistical analysis revealed 408 clustered genes that were significantly differentially expressed ( Figure 2B ). Gene Ontology (GO) pathway enrichment analysis revealed four predominant pathways being altered: cell migration, cytoskeletal organization, regulation of locomotion, and endopeptidase activity ( Figure 2C ). Enrichment for cellular components indicated several pathways being affected, especially concerning ECM organization and maintenance, including the exosome pathway ( Figure S1C ). Potential epithelial migration, namely that of AdvSCA-1 + progenitor cell migration toward the inner vascular wall, depends on the activity and gene expression of molecules able to disrupt the ECM, as well as promoting cytoskeletal rearrangements, including cell polarity. Our single-cell expression analysis revealed that matrix metallopeptidases, integrins, and collagen gene expression differed between ApoE KO and WT while AdvSCA-1 + cells in the mutant setting suggested a heightened epithelial-to-mesenchymal transition (EMT) ( Figure S1D ). Of note, 5% of WT AdvSCA-1 + cells expressed bone marrow hematopoietic progenitor genes, compared with 20% of the ApoE KO cells, from which a subpopulation of 10% was also positive for Cd45, 20% positive for Cd34, and 5% positive for Thy1 genes, as reported previously ( Figure S1E ; for review see Bobryshev et al., 2015) .
To address any mechanisms that allow mutant AdvSCA-1 + cells to migrate more prominently, we first enriched our single-cell expression analysis for those AdvSCA-1 + cells with a high copy of Sca-1 ( Figure 2D ), since in our established in vitro system setting passaged cells are used, which are highly enriched for SCA-1 through multiple magnetic bead cell sorting (Mayr et al., 2008; Yu et al., 2016) . Our findings were analyzed using genes known to correlate with epithelial mouse cell expression (Seo et al., 2010; Simpson et al., 2008) ( Figure 2E Figure 4C ). When ApoE KO cells + cells in both WT and ApoE KO EC layers of ascending and descending aortas (n = 14 independent experiments). Student's t test, p < 0.01. (E) En face immunohistochemical labeling of the adventitia of the descending aorta of WT and ApoE KO 6-month-old mouse SCA-1 (green), with notably more cells labeled in the ApoE KO adventitia (n = 3 mouse aortas). Scale bars, 10 mm.
were treated with DCN and transplanted to the WT extravascular cell wall of the femoral artery, they were mostly retained in the adventitial and medial layers. BMP1 inhibitor treatment caused an even distribution of transplanted cells throughout the vascular wall. These results demonstrate that DCN and BMP1 levels influence AdvSCA-1 + cell migration.
Based on these findings, we hypothesized that DCN and BMP1 may induce a synergistic effect on their most prominent target, collagen I (Ge and Greenspan, 2006; Keene et al., 2000) . To test this we set up 24-hr and 48-hr cell cultures of semi-confluent WT and ApoE KO AdvSCA-1 + , from which supernatant was collected. Collagens I, II, and III and BMP1 protein levels were measured via ELISA in the presence of DCN and/or iBMP1 ( Figures 4D and S3C ). Protein levels in untreated cell cultures were in sync with gene expression levels ( Figure 4E ). Collagen expression was altered in the ApoE KO in comparison with WT. DCN had no effect on collagen I protein in the ApoE KO, while collagens II and III were affected in the WT, implying a conditioned collagen assembly dysregulation in the ApoE-deficient progenitors. Direct inhibition of BMP1 affected collagens I, II, and III of the WT progenitors only. Administration of both reagents adjusted collagen expression. Figures  S3D and S3E ), we hypothesized that in vitro lipid loading would increase cell migration in wound-healing assays. Subsequent wound-healing assays also indicated a marked increase in the migration of chol-MbD-loaded cells when compared with untreated cells ( Figure 5C ). We confirmed these observations by documenting the migration of single AdvSCA-1 + progenitors using time-lapse microscopy showing that chol-MbD-loaded progenitor cells possessed increased migrational speed and persistence (Figures 5D and 5E) . Furthermore, immunofluorescence staining of the chol-MbD-loaded progenitors revealed F-actin reorganization, particularly nearer to the leading edge of the cells, as indicated by the yellow arrowheads in Figure 5F . Treatment with modified LDLs such as oxidized LDL (Ox-LDL) and acetylated LDL (Ac-LDL) also induced AdvSCA-1 + cell migration, to the same extent as cholMbD loading ( Figure S3 ), confirming that the effects of water-soluble cholesterol administration are similar to those of natural cholesterol carriers. Additional data from experiments performed using cell counting, bromodeoxyuridine assays, and cyclin D1 expression profiling with real-time RT-PCR indicated that chol-MbD, Ox-LDL, and Ac-LDL inhibited progenitor cell proliferation ( Figure S4 ). Together, these data suggest that cholesterol can induce SCA-1 + cell increased migration.
LDL-Bound and
Since AdvSCA-1 + progenitors have a potential to differentiate to other cells that make up the vascular wall, we investigated whether chol-MbD or modified LDL loading could induce this machinery. Interestingly, these molecules did not induce differentiation into foam cells judged by their gene expression profile ( Figure S5 ). Furthermore, the pre-treatment of progenitor cells with chol-MbD seemed to have resulted in inhibition of SMC-related (Figure 5G ) and EC-related ( Figure 5H ) gene expression. + cells were transduced with a nuclear RFP-inducing lentiviral construct. 1 3 10 6 cells in Matrigel plugs were transplanted to the outer side of the vascular wall of femoral arteries, in WT and ApoE KO 6-month-old animals. Cells were allowed to migrate for 24 and 72 hr prior to euthanizing the mice and assessing them with en face immunolabeling, using a VEcadherin (green) antibody to mark the endothelial cell layer. DAPI is blue. (B) Quantitative and spatial analysis of RFP + cells migrating from the adventitia to the lumen from the outer vascular wall after 24 and 72 hr. n = 3 transplantation experiments, geometric means, error bars with 95% CI. *p < 0.05, **p < 0.01. combined with chol-MbD, as shown using transwell and wound-healing assays ( Figure 6A ). These observations were confirmed in single-cell tracking experiments using time-lapse microscopy ( Figures 6B and 6C) . In a similar fashion, pre-treatments with Ox-LDL and Ac-LDL were also found to induce the migration of progenitor cells in response to TNF-a ( Figure S6D ).
MiRNA-29b
Mediates Cholesterol-Induced SCA-1 + Cell
Migration
We aimed to elucidate microRNA expression that drives the chol-MbD-mediated chemotactic induction of AdvSCA-1 + progenitors. We evaluated the potential changes of a panel of miRNA following loading with chol-MbD ( Figure S7A ). Chol-MbD markedly induced the expression of several miRNAs including miRNAs 29b-3p and 32-5p, while several miRNAs including 488-3p were inhibited. MicroRNAs 10a and 10b are known to act in a compensatory manner (for review see Feinberg and Moore, 2016) . The induction of miRNAs 29b-3p and 32-5p and inhibition of miRNA 488-3p were subsequently confirmed using real-time PCR (Figures S7B-S7F ).
MicroRNA 29b has been shown to participate in coronary artery disease (Chen et al., 2011) . To test whether miR29b is involved in the chol-MbD-mediated induction of AdvSCA-1 + progenitor migration, we overexpressed miRNA 29b in the AdvSCA-1 + progenitors by treating them with an mmu-miR-29b-3p mirVana miRNA mimic ( Figure 6D ). We observed that overexpression of miR-29 significantly increased SCA-1 + progenitor migration, both stochastically and in the presence of TNF-a. Subsequent experiments using an miRNA29 inhibitor showed a significant reduction in miR-29 levels and attenuated the migration of chol-MbD-mediated cells ( Figure 6E ). It is thus tempting to postulate that cholesterol can enhance AdvSCA-1 + progenitors' migratory response toward pro-inflammatory cytokines via miR-29b upregulation.
Cholesterol-Induced Migration Is Mediated by Sirtuin-1 Inhibition via MMP-9 Signaling
We next tested whether Sirtuin-1 (Sirt1) played a role in the chol-MbD-mediated effects, since this molecule has been involved in endothelial progenitor migration . Treatment of AdvSCA-1 + progenitor cells with chol-MbD resulted in a suppression of Sirt1 mRNA levels using RT-PCR ( Figure 7A) . Furthermore, the overexpression and inhibition of miR-29 were observed to cause an inhibition and induction of Sirt1 expression, respectively. Additionally the inhibition of SIRT1, using a specific inhibitor (EX-527), markedly increased AdvSCA-1 + progenitor cell migration, both randomly and toward TNF-a ( Figure 7B ). Furthermore, treatment with chol-MbD or miR-29 caused a marked increase in matrix metalloproteinase 9 (MMP-9) expression in AdvSCA-1 + progenitor cells ( Figures 7C and   7D ). Consistently, the inhibition of miR-29 and SIRT-1 in progenitor cells, in the presence of cholesterol, caused a reduction and increase in Mmp-9 expression, respectively ( Figure 7E ). We also observed that treatment with an MMP-9 inhibitor regulated chol-MbD-mediated migration, even in the presence of TNF-a ( Figure 7F ). Taken together, these data suggest that chol-MbD can induce MiR-29, which in turn suppresses Sirt1 and upregulates MMP-9 levels to induce AdvSCA-1 + progenitor cell migration.
DISCUSSION
Previous studies have demonstrated that adventitial fibroblasts migrate from the adventitia to the neointima upon balloon injury in rats (Li et al., 2000) , while AdvSCA-1 + progenitors potentially participate in neointimal aggravation of vein grafts (Hu et al., 2004) . Studies from our laboratory have demonstrated their potential role in native atherosclerosis (Mayr et al., 2008) . A recent report using lineagetracing analysis reported that more than 50% of neointimal + cells were transduced with a nuclear RFP-inducing lentiviral construct. Matrigel plugs containing 1 3 10 6 cells were transplanted to the outer side of the vascular wall, in WT and ApoE KO 6-month-old animals (n = 3 transplantation experiments). Cells were allowed to migrate for 72 hr prior to euthanizing the mice and assessing them with en face immunolabeling, using a VE-cadherin antibody to mark the EC layer. DAPI is blue. Quantitative and spatial analysis of RFP + cells migrating from the adventitia to the lumen from the outer vascular wall. *p < 0.05 and **p < 0.01 compared with the untreated group. (D) 3 3 10 4 WT or ApoE KO AdvSCA-1 + cells were seeded onto 12-well plates and treated with iBMP1 and/or DCN. Supernatant was collected after 24 hr. ELISA assays were performed against pro-collagens I and II, and collagen III. n = 3 independent experiments. *p < 0.05 compared with untreated control. *p < 0.05, WT compared with ApoE KO. (E) Heatmap of Sca-1 high cells differentially expressing Dcn, Bmp1, Col1a2, and Col3a1.
SMCs derived from adventitial stem cells (Kramann et al., 2016 (Beam et al., 2015) . A metabolomics analysis revealed a significant increase in fatty acid metabolites in ApoE KO AdvSCA-1 + progenitors (our unpublished data).
The presence of pro-collagen II is an indication of the unavoidable discrepancies that appear between in situ and in vitro experimental systems. It is also quite possible that since SCA-1 + cells were allowed to migrate for 24 hr, in the absence of leukemia inhibitory factor, they also began producing collagen II due to differentiation. There are several implications that derive from this study. We specifically link DCN and BMP1 to extracellular collagen remodeling in cholesterol-loaded AdvSCA-1 + cells; in contrast, microRNA 29b induces migration, possibly via Sirt1 (Schematic Diagram S1). DCN is a small leucine-rich proteoglycan that plays important roles in atherosclerosis (Singla et al., 2011 ). In Fischer et al. (2000 , reported an amelioration of intimal formation upon balloon injury in rats after Dcn gene overexpression. Although its expression is primarily observed in the tunica adventitia, it affects SMC response to growth factors (Fischer et al., 2001; Nili et al., 2003; Ueda et al., 2015) . Decorin overexpression reduces atherosclerosis in ApoE KO mice (Al Haj Zen et al., 2006) . Here, we show that in the same mouse model there is a shift of DCN expression/secretion from the adventitia to the medial layer. Whether this is a compensatory mechanism required for neointima stabilization remains to be elucidated. Studies performed in the skin of ApoE and DCN double KOs showed an overall reduced DCN expression, similar to our findings in the aorta (Hiebert et al., 2011) . In diabetic nephropathy, DCN acts in a protective manner, by reducing ECM accumulation (Merline et al., 2009) ; its absence attracts more mononuclear cells to the sites of insult, while in ocular fibroblasts a combination of suramin and DCN specifically inhibits collagen production (Mietz et al., 1997) . A recent study in abdominal aortic aneurysm showed that DCN stabilizes the ECM and inflammation, preventing induced pathology (Ueda et al., 2015) . The authors cautiously note the dual role of this molecule, promoting macrophage-induced pathology while ameliorating a vSMC-induced one. It is therefore highly likely that DCN's role in atherosclerosis is cell specific, as shown recently, in the human heart (Barallobre- Barreiro et al., 2016) .
DCN has been linked to collagen synthesis and BMP1 function (Keene et al., 2000; von Marschall and Fisher, 2010) . We found that Bmp1 is overexpressed in the mutant, while collagen I and collagen III gene expression was altered. The function of BMP1 on transforming growth factor b (TGF-b) cleavage has been reported (Ge and Greenspan, 2006) , while DCN also affects TGF-b's function (Ferdous et al., 2007) . BMP1 is a potent pro-collagen cleavage protease that is involved in atherosclerosis (Derwall et al., 2012) ; in fact, its reduction decreases vascular wall calcification. We hypothesized that these molecules act synergistically in collagen production in AdvSCA-1 + cells. The addition of iBMP1 nearly abolished AdvSCA-1 + migration, with minimal cell toxicity, while DCN addition affected only ApoE KO SCA-1 + cells but not WT SCA-1 + cells. Thus, Figure 5 . Cholesterol Induces SCA-1 + Cell Migration and Inhibits Differentiation (A and B) 1 3 10 5 WT or ApoE KO AdvSCA-1 + cells were loaded with 20 mg/mL cholesterol along with 10 mg/mL iBMP1 and/or DCN in serumfree media and allowed to pass through 8.0-mm transwells in the presence of 0.2% FBS for 24 hr. (C) Migration of SCA-1 + progenitor cells was evaluated using a wound-healing assay. Migration index for both assays was defined as the mean number of progenitors counted per 5 random fields of view at 203. (D) Vascular progenitor cells were seeded at 1 3 10 4 cells per well of 6-well plate and subjected to 48 hr of 20 mg/mL chol-MbD loading. (E) Single-cell migration was documented using time-lapse microscopy, and quantified for speed and persistence. (F) Changes in F-actin distribution was analyzed (yellow arrowheads) using immunofluorescence staining with phalloidin (Alexa 488; green) and DAPI (blue). (G and H) The effect of cholesterol on smooth muscle cell (G) and endothelial cell (H) differentiation was observed using phase-contrast light microscopy. Black arrows represent a change in cell morphology. Total RNA was harvested for analysis of smooth muscle cell gene expression using real-time RT-PCR. Graphs are shown as mean ± SEM of three independent experiments (n = 3). *p < 0.1, **p < 0.05, ***p < 0.01 compared with untreated control. Scale bars, 20 mm. (B and C) SCA-1 + cells were seeded at 5 3 10 3 cells per well of 6-well plate and subjected to 48 hr of 20 mg/mL chol-MbD loading and 10 ng/mL TNF-a. Single-cell migration was documented using time-lapse microscopy and quantified for speed and persistence.
(legend continued on next page) addition of DCN or DCN/iBMP1 fine-tunes ApoE KO AdvSCA-1 + cells into a perhaps more WT AdvSCA-1 + migratory (atheroprotective) behavior. The search for cues important for AdvSCA-1 + migration led us to investigate a cohort of miRNAs in relation to this. Lipid loading showed that ApoE KO progenitors were indeed more prone to migrate toward SMCs, possibly due to their altered ECM gene expression profile. Recently, we reported that AdvSCA-1 + cells respond to vSMC-derived chemokine cues contributing to neointima formation (Yu et al., 2016) . Since 1998, when the ApoE KO mouse model was employed for studies of atherosclerosis and hyperlipidemia (Hofker et al., 1998) , it has not been shown how LDLs contribute to specific effects on AdvSCA-1 + cells. It has been recently documented that DNA hypomethylation is important for the onset of the disease, along with lifestyle factors (Jiang et al., 2012) . Thus, miRNA expression levels may have a strong influence in controlling the disease. Our experiments show that miR-29b elicits a response to the migratory potential of lipid-loaded AdvSCA-1 + ,
(D and E) Migration of SCA-1 + cell toward serum-free media, loaded with 20 mg/mL chol-MbD and in the presence of hsa-miR-29b-3p miRNA inhibitor. Scale bars, 100 mm. (F and G) Migration of SCA-1 + cell toward serum-free media, or loaded with 20 mg/mL chol-MbD and TNF-a (10 ng/mL) in the presence of hsa-miR-29b-3p miRNA and its inhibitor. Data in graphs are shown as mean ± SEM of three independent experiments. *p < 0.1, **p < 0.05, ***p < 0.01 compared with untreated control. (E) SCA-1 + cells were pre-loaded with cholMbD and treated with a hsa-miR-29b-3p ID: MH10103 mirVana miRNA inhibitor or 50 mM EX-527. Cell lysates were harvested and subjected to real-time RT-PCR. (F) The effect of MMP-9 inhibition (pretreatment with 20 mM MMP-9 inhibitor II) on the migration of chol-MbD loaded cells toward serum-free media or TNF-a (10 ng/mL) was evaluated using 8.0-mm transwell assays. Data in graphs are shown as mean ± SEM of three independent experiments. *p < 0.1, **p < 0.05, ***p < 0.01 compared with untreated control.
possibly via Sirt1 and MMP-9, with the latter documented to play a role in atherosclerosis (Chen et al., 2008; Gough et al., 2006; Pleva et al., 2015) , while the former is a molecule now shown to be involved in AdvSCA-1 + progenitors.
Of note, it has been reported that human MiR-29b has been implicated in ECM remodeling including collagen regulation (Kriegel et al., 2012) , while its dysregulation in murine cardiac fibroblasts upon post-myocardial infraction led to decreased collagen formation and fibrosis (van Rooij et al., 2008) . It was also interesting how pro-inflammatory cytokines such as TNF-a affected this pathway, meaning that innate immunity may play a crucial role. Atherosclerosis is a chronic inflammatory disease characterized by lipoprotein accumulation that carries cholesterol inside the arteries. Accumulation of LDL and cholesterol leads to aberrant activation of vSMCs and macrophages within the vessel wall (Xu et al., 2015) . Modified LDLs have been also known to increase foam cell formation, influencing lesion development (Cox et al., 2007) . Although these molecules have been implicated in pro-and antiatherosclerotic responses, their effect on Sca-1 + progenitors
has not been investigated. Loading of AdvSCA-1 + with
MbD had an immediate effect on their migration potential, causing cytoskeletal rearrangements characteristic of increased locomotion. Ox-and Ac-LDL administration had a modest effect on migration, along with affecting SCA-1 + cell proliferation and viability; in line with these results, mRNA levels of known scavenger receptors that bind modified LDL molecules such as Cd63, Cd68, Lox-1, Msra, and others remained unchanged. We thus attempted to identify the mechanism by which chol-MbD induces SCA-1 + ECM modifications that induce migration. The role of MMP-9 in this process has been documented in macrophage function and arterial enlargement during atherosclerosis (Chen et al., 2008; Gough et al., 2006; Karwowski et al., 1999; Tronc et al., 2000) . While this paper was being written, it was reported that Mmp-9-deficient mice had an abnormal cholesterol metabolism, leading to atherosclerosis (Hernandez-Anzaldo et al., 2016) . Here, we show that AdvSCA-1 + MMP-9 levels were elevated significantly upon exposure to chol-MbD, underscoring the potential ability of AdvSCA-1 + to alter the ECM. Based on this, we investigated whether Sirt1 inhibition, whose expression has been reported to inhibit atherosclerosis in vSMCs (Gorenne et al., 2013) , also had an effect on SCA-1 + progenitor migration. Indeed, by using a specific inhibitor or loading with chol-MbD, progenitors' migration index was increased in a linearly inverted fashion. MicroRNA 29b-3p expression levels affected chol-MbDloaded AdvSCA-1 + . Two of the mechanisms of action were via a modest Sirt1 change and a massive MMP-9 upregulation. To our knowledge, no report has shown to date that an miRNA can alter the lipid-loaded migratory effect of AdvSCA-1 + progenitors.
In summary, our results provide some clarity of the migratory mechanisms of resident AdvSCA-1 + progenitors.
(1) Hyperlipidemic mice possess more HSC-derived progenitors in the adventitia, in concert with previous studies (Hu et al., 2002a (Hu et al., , 2002b ; (2) AdvSCA-1 + cells from ApoE KO mice are undergoing EMT, which could be an early sign of vascular stiffening; (3) ApoE KO AdvSCA-1 + cells have a higher migratory potential than their WT counterparts; finally, (4) it seems that the AdvSCA-1 + ApoE KO cells show an altered ECM, possibly due to dysfunctional lipid loading, which may trigger or augment an unwanted para-inflammatory immune response, a characteristic of age-related disease (Chen et al., 2012; Xu et al., 2009) . Therefore, these results could provide a potential strategy for the treatment of atherosclerosis by directing adventitial cell migration.
EXPERIMENTAL PROCEDURES

Animals
All animal procedures were performed according to the protocol reviewed by the Institution Ethics Committee and approved by the UK Home Office. All mice used were on identical genetic background.
Single-Cell Gene Expression Analysis
Mouse adventitial cells were collected and pooled from six aortas of 6-month-old mice, for each genotype. SCA-1 + cells were isolated from primary cultured cells upon reaching 90% confluence using a microbeads kit (Miltenyi Biotec, Bergisch Gladbach, Germany) containing anti-SCA-1 immunomagnetic microbeads and a magnetic cell-sorting system column. Cells were further analyzed using the Fluidigm C1 machine and workflow following the manufacturer's protocol.
AdvSCA-1 + Progenitor Cell Culture and Differentiation
Mouse adult progenitor cells were derived from an outgrowth of adventitial tissues of vessel grafts as previously described (Hu et al., 2004; Tsai et al., 2012) .
Cell Transplantations
For the in vivo cell transplantations, 1 3 10 6 cells were immersed in Matrigel for 30 min on ice prior to transplanting them to the extra-adventitial space of the femoral artery of 6-month-old mice. Decorin and iBMP1 were administered along with the Matrigel, where appropriate. Mice were then euthanized 24 and 72 hr later, and femoral arteries were collected and fixed on 4% paraformaldehyde for 15 min prior to further analysis.
Exogenous Proteins, Antagonists, Cholesterol, and Modified LDL Loading 
MicroRNA Transient Transfection
Manipulation of miRNA levels in vascular progenitor cells (cultured to 60%-70% confluence) was carried out using an mmu-miR-29b-3p mouse mirVana miRNA mimic (5 mM), according to the manufacturer's protocol. 
SUPPLEMENTAL INFORMATION
